This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home   Membership   Events   Resources   Accreditation Feb. 22, 2012

ACRO 2012: Billing and Coding Seminar presented by Revenue Cycle to take place today
ACRO    Share   Share on FacebookTwitterShare on LinkedinE-mail article
When: 3:45 p.m. today, Wednesday, Feb. 22
Where: Caloosa B, Sanibel Harbour Marriott
Attending the ACRO 2012 Annual Meeting in Fort Myers, Fla.? Interested in learning what the changes to CMS reimbursement means to your practice? Please join Ron Digiaimo and the RCI team for an in-depth two-hour CME approved session on this topic. Please note: The start time on this course has been changed from the previously advertised start time of 1:30 p.m.

FDA: Shortage of children's cancer drug can be averted
USA Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The U.S. Food and Drug Administration has managed to avert a "crisis" for children with cancer by preventing a looming shortage of a lifesaving drug, officials announced. The shortage of methotrexate — a mainstay of treatment for children with acute lymphoblastic leukemia — is the latest in a series of serious shortages of cancer medications and other drugs that have frustrated doctors and patients over the past year and a half. More

Cancer screening budget cuts may prove deadly for some women
The Huffington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Government budget cuts may prove deadly for low-income women who increasingly are unable to get critical cancer screenings that once were offered free by state governments. Shrinking state and federal budgets, the elevated cost of top-notch testing and growing demand are leaving millions of uninsured women unable to access breast and cervical screening programs. More

It's About Time

Learn more about this follicular lymphoma treatment at the link below.

Scientists score big breakthrough in treating cancer with nanobots
PC Magazine    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Harvard scientists have developed a cell-sniffing nanorobot that can deliver payloads of drug molecules to cancer-stricken areas of a person's body. The researchers said in a peer-reviewed study that they used their nanobots to deliver antibodies to lymphoma, leukemia, and other types of cancer cells, succeeding in halting their growth. The study describing experiments with the device prototype was published in this week's edition of the journal Science by Shawn Douglas, Ido Bachelet, and George Church of the Harvard Medical School's Wyss Institute for Biologically Inspired Engineering and Department of Genetics. More

Study: No cancer benefits seen in supplements
The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new study testing B vitamins and omega-3 fatty acids for cancer prevention has found no beneficial effect and — at least for women — some possibility of harm. In this placebo-controlled five-year study, published in The Archives of Internal Medicine, French researchers divided 2,501 survivors of cardiovascular illness ages 45 to 80 into four groups. The first took daily supplements of vitamin B9, vitamin B6 and vitamin B12; the second took two kinds of omega-3 fatty acids; the third took vitamin B6, vitamin B12 and omega-3; and the last took a placebo. More

8 ways to keep from becoming another breast cancer casualty
The Atlantic    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Stacey Vitiello writes, "I wear my seatbelt, get my flu shot, wash and sanitize my hands, wear sunscreen, scrub the fruits and veggies clean, look both ways when I cross the street, and never take candy from strangers. But what can I do to protect myself (and my family) from the single most common cause of death among women in my own age group, 35 to 50 years old? The following are a few evidence-based strategies to increase your odds of avoiding advanced breast cancer." More

Blood thinners may help treat ovarian cancer
Los Angeles Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
As many as one-third of women with ovarian cancer have high levels of platelets in their blood, which is linked to worse outcomes, researchers reported. Platelets are components of cells that clump together to stop bleeding. Having an excessively high level of platelets is called thrombocytosis. Doctors have long known that thrombocytosis is associated with cancer. In the new study, published in the New England Journal of Medicine, researchers at M.D. Anderson Cancer Center in Houston analyzed data from 619 women with ovarian cancer. More

ONCOCHART now in the cloud!

ONCOCHART, the 1st ARRA-certified RadOnc EMR, can be deployed either in a local environment or “cloud” environment. See us at ACRO Booth 21 for complete details.

After denying son cancer treatment but treating their dog for fleas, Ohio couple gets 8 years in prison
Fox News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The parents of an 8-year-old boy who died from Hodgkin lymphoma after suffering for months from undiagnosed swollen glands was sentenced to eight years in prison after pleading guilty to denying him medical treatment. Attorneys for Monica Hussing, 37, and William Robinson Sr., 40, had said the parents had financial problems and tried to get checkups for their son but couldn't afford it. The couple was given the maximum sentence by Cuyahoga County Judge Michael Astrab, who accepted their guilty plea last month to attempted involuntary manslaughter in a last-minute plea deal before their trial was about to begin. More

Cancer patients fume over counterfeit Avastin
ABC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Cancer patients are furious that a counterfeit version of the drug Avastin has landed in U.S. clinics. Avastin, which is made by the California-based company Genentech, is used in combination with chemotherapy to treat cancers of the colon, brain, kidneys and lungs. But the counterfeit lacks the tumor-starving ingredient some patients need to survive. "It's an outrage," said Diane Barraza, 48, who takes Avastin for stage IV colon cancer. "For a company to sell this drug, put it in our blood, it's an outrage." More

Catalyst - Reinforcing the Treatment Chain
Improve patient throughput whilst ensuring patient safety. The Catalyst is an optical scanner which creates a 3D model of the patient surface and projects positional delta directly onto the patient providing continual feedback for the Therapist. Movement during the fraction is detected triggering a visual and audible alarm. more

Government panel favors some WTC cancer claims
The Associated Press via The Wall Street Journal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A $2.76 billion aid program for people sickened by World Trade Center dust should be expanded to include those who have at least some types of cancer, members of a government advisory panel said. Congress set aside a huge pot of money last year to compensate and treat people exposed to the clouds of toxic soot released during the collapse of the twin towers on Sept. 11, 2001, but lawmakers concerned about runaway costs and illegitimate health claims also limited the program to people suffering from a relatively short list of illnesses, including asthma, acid reflux and certain chronic sinus problems. More

Cancer trial participants may have misconceptions
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
People enrolled in early stage trials for possible cancer treatments may underestimate the risks involved and overestimate the potential benefits, suggests a new study. The early trials, known as "Phase 1," are often the first time a new drug is given to humans and the goal of the studies is to test for side effects and acceptable dosage levels. Participation rarely benefits the person's health. One of the new report's authors says it's well known that people taking part in early trials confuse the research for medical care, but it goes beyond that. More

Which cancers are increasing among older adults?
AARP    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Cancers of the mouth and throat related to oral sex, as well as thyroid, liver and skin cancers are on the rise among older adults, according to new stats released recently from the American Cancer Society. There was some good news, however. The death rate is down for the well-known major cancers. The society's Cancer Statistics 2012 report found that overall, cancer deaths dropped by nearly 2 percent for both men and women from 2004 to 2008. More

Cancer drug erases Alzheimer's in mice
ABC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A drug typically used to treat skin cancer quickly reversed Alzheimer's disease in mice, according to a study published today in the journal Science. Alzheimer's researchers call the results exciting, but they remain cautious about the drug's ability to fight the disease in humans. Researchers at Case Western Reserve University gave the drug to mice that had brain hallmarks of Alzheimer's disease: abnormal protein plaques and tangles, which destroy the brain's centers for memory and cognitive function. More
RadOnc Weekly
Colby Horton, Vice President of Publishing, 469.420.2601   Download media kit
Patrick McCoy, Senior Content Editor, 469.420.2603   Contribute news
This edition of RadOnc Weekly was sent to %%emailaddr%%. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Feb. 22, 2012
Feb. 15, 2012
Feb. 8, 2012
Feb. 1, 2012

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063